GAMELIN ERICK (Chief Development Officer) reported 1 transaction at ACRIVON THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/18/2026ACC: 0000905148-26-002500
Officer· Chief Development Officer
Since Mar 2026
-404.00
Net shares
Net seller
$775.68
Total sold
0
Open market trades
0B · 0S
1
Total transactions
404.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−404.00
Price / share
$1.92
Trade value
$775.68
% of position
2.7%
5/14/2026
14.81K→14.41K
Total
Net shares
−404.00
Net value
-$775.68
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2026 | F · Tax Withholding | −404.00 | $1.92 | $775.68 | 2.7% | 14.81K | 14.41K |
| Total | −404.00 | -$775.68 | ||||||
Derivative Transactions0
No derivative transactions reported